Literature DB >> 22980292

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.

Sumeet Subherwal, Kevin J Anstrom, William S Jones, Michael G Felker, Sanjay Misra, Michael S Conte, William R Hiatt, Manesh R Patel.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22980292      PMCID： PMC3950277          DOI： 10.1016/j.ahj.2012.07.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  43 in total

1.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 3.  Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.

Authors:  R M Califf; L Harrelson-Woodlief; E J Topol
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.

Authors:  Stuart J Pocock; Cono A Ariti; Timothy J Collier; Duolao Wang
Journal:  Eur Heart J       Date:  2011-09-06       Impact factor: 29.983

5.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

6.  Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.

Authors:  Ryuichi Morishita; Motokuni Aoki; Naotaka Hashiya; Hirofumi Makino; Keita Yamasaki; Junya Azuma; Yoshiki Sawa; Hikaru Matsuda; Yasufumi Kaneda; Toshio Ogihara
Journal:  Hypertension       Date:  2004-07-06       Impact factor: 10.190

7.  Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

Authors:  Satoaki Matoba; Tetsuya Tatsumi; Toyoaki Murohara; Tsutomu Imaizumi; Yousuke Katsuda; Masaaki Ito; Yoshihiko Saito; Shiro Uemura; Hiroshi Suzuki; Shinya Fukumoto; Yasutaka Yamamoto; Rie Onodera; Satoshi Teramukai; Masanori Fukushima; Hiroaki Matsubara
Journal:  Am Heart J       Date:  2008-09-19       Impact factor: 4.749

8.  Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.

Authors:  Richard J Powell; Michael Simons; Farrel O Mendelsohn; George Daniel; Timothy D Henry; Minako Koga; Ryuichi Morishita; Brian H Annex
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

9.  Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease.

Authors:  Michael C Stoner; Dorian J deFreitas; Sachin V Phade; Frank M Parker; William M Bogey; Steve Powell
Journal:  J Vasc Surg       Date:  2007-06-27       Impact factor: 4.268

Review 10.  Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

Authors:  Michael S Conte; Patrick J Geraghty; Andrew W Bradbury; Nathanael D Hevelone; Stuart R Lipsitz; Gregory L Moneta; Mark R Nehler; Richard J Powell; Anton N Sidawy
Journal:  J Vasc Surg       Date:  2009-11-07       Impact factor: 4.268
View more
  8 in total

1.  Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease.

Authors:  Kevin D Hill; H Scott Baldwin; David P Bichel; Alicia M Ellis; Eric M Graham; Christoph P Hornik; Jeffrey P Jacobs; Robert D B Jaquiss; Marshall L Jacobs; Prince J Kannankeril; Jennifer S Li; Rachel Torok; Joseph W Turek; Sean M O'Brien
Journal:  Am Heart J       Date:  2020-05-20       Impact factor: 4.749

2.  Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.

Authors:  Roland A Matsouaka; Rebecca A Betensky
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

3.  An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.

Authors:  Roland A Matsouaka; Aneesh B Singhal; Rebecca A Betensky
Journal:  Stat Methods Med Res       Date:  2016-12-29       Impact factor: 3.021

4.  Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.

Authors:  Amish N Raval; Eric G Schmuck; Girma Tefera; Cathlyn Leitzke; Cassondra Vander Ark; Derek Hei; John M Centanni; Ranil de Silva; Jill Koch; Richard G Chappell; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-09-18       Impact factor: 5.414

5.  Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.

Authors:  Sumeet Subherwal; Manesh R Patel; Karen Chiswell; Beth A Tidemann-Miller; W Schuyler Jones; Michael S Conte; Christopher J White; Deepak L Bhatt; John R Laird; William R Hiatt; Asba Tasneem; Robert M Califf
Journal:  Circulation       Date:  2014-09-19       Impact factor: 29.690

6.  Postoperative Pulmonary Complications' Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis.

Authors:  Gen Li; Robert E Freundlich; Rajnish K Gupta; Christina J Hayhurst; Chi H Le; Barbara J Martin; Matthew S Shotwell; Jonathan P Wanderer
Journal:  Anesthesiology       Date:  2021-06-01       Impact factor: 8.986

Review 7.  Lower extremity amputation in peripheral artery disease: improving patient outcomes.

Authors:  Aparna Swaminathan; Sreekanth Vemulapalli; Manesh R Patel; W Schuyler Jones
Journal:  Vasc Health Risk Manag       Date:  2014-07-16

8.  Win Ratio -An Intuitive and Easy-To-Interpret Composite Outcome in Medical Studies.

Authors:  Hongyue Wang; Jing Peng; Juila Z Zheng; Bokai Wang; Xiang Lu; Chongshu Chen; Xin M Tu; Changyong Feng
Journal:  Shanghai Arch Psychiatry       Date:  2017-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.